Competitive selection, trade, and employment:The strategic use of subsidies

We thank Holger Görg, Philipp Schröder, Fredrik Sjöholm, participants at the Danish International Economics Workshop, seminar participants at Aberdeen, Sheffield and Loughborough, three anonymous referees and the Editor of the journal, for helpful comments and suggestions. Funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 290647 is gratefully acknowledged.Peer reviewedPostprin

The Muon Identification Procedure of the LHCb Experiment for the First Data

We present a refined muon identification algorithm for the LHCb experiment suitable for the first period of data taking. The new algorithm is robust against possible inefficiencies of the Muon Detector and takes properly into account the momentum dependence, so it can be tuned with calibration samples and exported to signal samples with different momentum spectra without large corrections. The average performance depends on the momentum spectrum of the analyzed sample: with the current simulation we find for tracks with p > 3 GeV/c in a generic b-inclusive sample a muon identification efficiency of 90 % for a misidentification rate of hadrons and electrons of ~2.4 % (~ 1 % excluding pi's and K's decays in flight). Additional rejection power can be obtained by combining in a proper way the informations coming from all the other subdetectors in a global Likelihood: in this case for a muon identification efficiency of 90 % we find a misidentification rate of ~1.8 % (~ 0.8 % excluding pi's and K's decays in flight

Performance of the Muon Identification at LHCb

The performance of the muon identification in LHCb is extracted from data using muons and hadrons produced in J/\psi->\mu\mu, \Lambda->p\pi and D^{\star}->\pi D0(K\pi) decays. The muon identification procedure is based on the pattern of hits in the muon chambers. A momentum dependent binary requirement is used to reduce the probability of hadrons to be misidentified as muons to the level of 1%, keeping the muon efficiency in the range of 95-98%. As further refinement, a likelihood is built for the muon and non-muon hypotheses. Adding a requirement on this likelihood that provides a total muon efficiency at the level of 93%, the hadron misidentification rates are below 0.6%.Comment: 17 pages, 10 figure

Performance of a multigap RPC prototype for the LHCb muon system

Several technologies are under consideration for the muon system of the LHCb experiment. Resistive Plate Chambers (RPCs) are one of the favourite candidates for the outer areas where the particle fluxes are expected to be at most some kHz/cm/sup 2/. This work describes the results obtained with a multigap RPC prototype under various beam conditions at the CERN facilities. (9 refs)

An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia

This study aimed to assess the efficacy and tolerability of atorvastatin in Tanner stage (TS) 1 patients ages 6 to 10 years and TS ≥2 patients ages 10 to <18 years with genetically confirmed heterozygous familial hypercholesterolemia (HeFH) and a low density lipoprotein cholesterol (LDL-C) level of 4 mmol/l (155 mg/dl) or higher. In this open-label, 8-week study, 15 TS 1 children were treated initially with atorvastatin 5 mg/day and 24 TS ≥2 children with 10 mg/day. Doses were doubled at week 4 if the LDL-C target (<3.35 mmol/l [130 mg/dl]) was not achieved. The efficacy variables were the percentage change from baseline in LDL-C, total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), very low density lipoprotein cholesterol (VLDL-C), and apolipoprotein (Apo) A-I and Apo B. Safety evaluations included clinical monitoring, subject-reported adverse events (AEs), vital signs, and clinical laboratory tests. The mean values for LDL-C, TC, VLDL-C, and Apo B decreased by week 2 among all TS 1 and TS ≥2 patients, whereas TG, HDL-C, and Apo A-I varied considerably from week to week. After 8 weeks, the mean reduction in LDL-C was −40.7% ± 8.4 for the TS 1 children and −39.7% ± 10.3 for the TS ≥2 children. For the TS 1 patients, the mean reductions were −34.1% ± 6.9 for TC and −6.0% ± 32.1 for TG. The corresponding changes for the TS ≥2 patients were −35.6% ± 9.5 for TC and −21.1% ± 29.7 for TG. Four patients experienced mild to moderate treatment-related AEs. No serious AEs or discontinuations were reported. Overall, no difference in safety or tolerability was observed between the younger and older cohorts. Across the range of exposures after atorvastatin 5 to 10 mg (TS 1) or atorvastatin 10 to 20 mg (TS ≥2) doses for 8 weeks, clinically meaningful reductions in LDL-C, TC, VLDL-C, and Apo were observed with atorvastatin in pediatric patients who had HeFH. Atorvastatin also was well tolerated in this population

Differential branching fraction and angular analysis of the decay B0→K∗0μ+μ−

The angular distribution and differential branching fraction of the decay B 0→ K ∗0 μ + μ − are studied using a data sample, collected by the LHCb experiment in pp collisions at s√=7 TeV, corresponding to an integrated luminosity of 1.0 fb−1. Several angular observables are measured in bins of the dimuon invariant mass squared, q 2. A first measurement of the zero-crossing point of the forward-backward asymmetry of the dimuon system is also presented. The zero-crossing point is measured to be q20=4.9±0.9GeV2/c4 , where the uncertainty is the sum of statistical and systematic uncertainties. The results are consistent with the Standard Model predictions